Context in source publication

Context 1
... is an orally administered, small molecule inhibitor of phosphodiesterase 4(PDE4). (Figure 4) .Apremilast 30 mg twice daily reduced the severity of moderate to severe plaque psoriasis in the phase 3 ESTEEM trials, as well as improving difficult-to-treat nail, scalp and palmoplantar psoriasis. [6 a,b} ...

Similar publications